NASDAQ:SNDXSyndax Pharmaceuticals Competitors & Alternatives

$16.85

+1.16 (+7.39 %)

(As of 05/27/2020 04:00 PM ET)

Add

Compare

Today's Range

$15.10

Now: $16.85▼

$17.10

50-Day Range

$9.14

MA: $14.97▼

$20.98

52-Week Range

$5.35

Now: $16.85▼

$21.97

Volume1.11 million shs

Average Volume605,591 shs

Market Capitalization$608.20 million

P/E RatioN/A

Dividend YieldN/A

Beta1.93

Syndax Pharmaceuticals (NASDAQ:SNDX) Competitors and Alternatives

The following companies in the "pharmaceutical preparations" industry are considered alternatives and competitors to Syndax Pharmaceuticals.

Competitor Name	Beat the Market Rank	Current Price	Price Change	Market Cap	Revenue	P/E Ratio	Indicator(s)
RARX Ra Pharmaceuticals	0.7	$47.99	+0.0%	$2.27 billion	$3 million	-20.77
TGTX TG Therapeutics	1.7	$20.50	+0.4%	$2.22 billion	$150,000.00	-10.10
KRTX Karuna Therapeutics	1.5	$87.97	+3.0%	$2.16 billion	N/A	-0.60	Analyst Downgrade Insider Selling Heavy News Reporting
PRNB Principia Biopharma	1.2	$67.88	+0.7%	$2.15 billion	$35.16 million	-27.82
PBH Prestige Consumer Healthcare	1.6	$44.07	+4.3%	$2.11 billion	$963.01 million	15.85
TPTX Turning Point Therapeutics	1.1	$65.95	+3.2%	$2.11 billion	N/A	-18.32	Analyst Report Insider Buying
SAGE SAGE Therapeutics	1.6	$37.71	+3.6%	$2.03 billion	$6.87 million	-3.03	Analyst Report
EPZM Epizyme	1.6	$18.84	+1.0%	$1.98 billion	$23.80 million	-9.28
MDGL Madrigal Pharmaceuticals	1.6	$120.00	+0.4%	$1.94 billion	N/A	-17.62
IRWD Ironwood Pharmaceuticals	1.4	$10.65	+9.9%	$1.91 billion	$428.41 million	20.09	High Trading Volume Heavy News Reporting

PCRX Pacira Biosciences	1.6	$44.65	+0.2%	$1.84 billion	$421.03 million	-2,231.38	Analyst Report
AUPH Aurinia Pharmaceuticals	1.8	$15.94	+0.3%	$1.82 billion	$320,000.00	-12.17
CORT Corcept Therapeutics	1.3	$15.15	+3.0%	$1.80 billion	$306.49 million	17.22
EIDX Eidos Therapeutics	1.1	$48.51	+3.9%	$1.80 billion	$26.69 million	-36.75	Analyst Upgrade
XNCR Xencor	1.4	$32.17	+0.2%	$1.80 billion	$156.70 million	-30.07
IGMS IGM Biosciences	1.0	$63.30	+1.0%	$1.78 billion	N/A	-13.19
TBPH Theravance Biopharma	1.5	$25.11	+6.3%	$1.73 billion	$73.41 million	-5.79
ARVN Arvinas	1.6	$42.88	+3.6%	$1.72 billion	$42.98 million	-19.40	Analyst Downgrade High Trading Volume
DRNA Dicerna Pharmaceuticals	1.7	$20.39	+6.7%	$1.71 billion	$23.90 million	-12.07
HRTX Heron Therapeutics	1.4	$19.00	+2.9%	$1.69 billion	$145.97 million	-8.37	Analyst Report
ZGNX Zogenix	2.2	$29.78	+1.8%	$1.66 billion	$3.65 million	-3.15
RCUS Arcus Biosciences	1.4	$27.05	+24.0%	$1.65 billion	$15 million	-12.52	Analyst Report High Trading Volume Heavy News Reporting
ZYME Zymeworks	2.0	$39.01	+2.1%	$1.65 billion	$29.54 million	-10.03
LGND Ligand Pharmaceuticals	1.4	$104.77	+1.0%	$1.61 billion	$120.28 million	-30.46
CNST Constellation Pharmaceuticals	1.4	$33.47	+3.6%	$1.55 billion	N/A	-11.46	Analyst Upgrade High Trading Volume
AKBA Akebia Therapeutics	1.7	$12.29	+1.1%	$1.55 billion	$335 million	-5.56
AMRX Amneal Pharmaceuticals	2.2	$4.95	+0.4%	$1.52 billion	$1.63 billion	-3.07
OPK Opko Health	2.3	$2.29	+0.9%	$1.51 billion	$901.90 million	-4.77	Analyst Downgrade Insider Buying
YMAB Y-mAbs Therapeutics	1.5	$39.14	+0.9%	$1.50 billion	N/A	-15.72	Insider Selling
AKCA Akcea Therapeutics	1.2	$15.08	+0.9%	$1.48 billion	$488.54 million	-50.27
ITCI Intra-Cellular Therapies	1.5	$22.02	+0.1%	$1.46 billion	$60,000.00	-7.92
INVA Innoviva	1.5	$14.60	+3.1%	$1.44 billion	$261.02 million	8.54
ZNTL Passage Bio	1.9	$41.72	+5.0%	$1.40 billion	N/A	0.00
PTLA Portola Pharmaceuticals	1.5	$17.89	+0.4%	$1.40 billion	$116.64 million	-4.75
KPTI Karyopharm Therapeutics	1.8	$18.81	+2.6%	$1.37 billion	$40.89 million	-6.44	Analyst Upgrade
TCDA Tricida	1.8	$27.03	+0.7%	$1.36 billion	N/A	-6.29	High Trading Volume
ZEAL ZEALAND PHARMA/S	0.8	$36.90	+2.6%	$1.29 billion	$6.20 million	-13.67	High Trading Volume
SUPN Supernus Pharmaceuticals	1.8	$24.34	+2.0%	$1.28 billion	$392.76 million	11.21
CYTK Cytokinetics	1.6	$21.25	+3.1%	$1.23 billion	$26.87 million	-9.49
IMAB Phoenix Tree	1.0	$24.25	+5.4%	$1.22 billion	$4.31 million	-0.84	Heavy News Reporting
RVNC Revance Therapeutics	1.7	$22.05	+2.7%	$1.21 billion	$410,000.00	-5.57
PHAT Phathom Pharmaceuticals	1.9	$43.78	+1.1%	$1.20 billion	N/A	-3.13
MGNX MacroGenics	1.3	$23.14	+2.2%	$1.16 billion	$64.19 million	-7.49	Analyst Report
ARCT Arcturus Therapeutics	0.9	$38.56	+40.8%	$1.16 billion	$20.79 million	-18.72	High Trading Volume
MYOV Myovant Sciences	1.9	$12.48	+0.6%	$1.14 billion	N/A	-3.70
ARQT I-Mab	1.6	$30.20	+0.8%	$1.13 billion	N/A	0.00
AIMT Aimmune Therapeutics	2.4	$17.11	+0.2%	$1.11 billion	N/A	-3.85	Analyst Downgrade
KNSA Kiniksa Pharmaceuticals	1.2	$20.81	+4.6%	$1.10 billion	N/A	-9.33
RCKT Rocket Pharmaceuticals	2.4	$20.02	+2.4%	$1.10 billion	N/A	-12.51
ESPR Esperion Therapeutics	2.0	$39.75	+3.5%	$1.10 billion	$148.36 million	-4.13